Altre lingue Jaguar Health, Inc.

Azioni

JAGX

US47010C7065

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
0,2147 ^USD	+3,22%		+27,80%	+41,81%

19/04	Venture Life rinnova la linea di credito revolving con Santander e HSBC	AN
18/04	Jaguar Health, Inc. nomina Catherine Miller Collis nel ruolo di Vicepresidente senior della Strategia di crescita	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion about Microvillus Inclusion Disease	30/04
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care	23/04
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care	19/04
Venture Life renews revolving credit facility with Santander and HSBC	19/04
Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy	18/04
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders	10/04
Wall Street Set to Open Sharply Lower Wednesday as Inflation Rises More Than Expected	10/04
Exchange-Traded Funds Down, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Meeting Minutes	10/04
Top Premarket Gainers	10/04
Jaguar Health Granted Extension until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement	09/04
Jaguar Health : Corporate Presentation – April 1, 2024	05/04
Jaguar Health, Inc. Appoints Massimo Radaelli, PhD, as President of Jaguar International	04/04
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International	03/04
Jaguar Health Reports 2023 Financial Results	02/04
Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials and Corporate Updates	28/03
Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance	26/02
Jaguar Health Reaches Agreement With FDA on Design, Conduct of Medicine Study	15/02
Jaguar Health, Inc. Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea in Dogs	15/02
Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief	15/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jaguar Health, Inc.

Azioni

JAGX

US47010C7065

Altre lingue

Filtri